Acid sphingomyelinase deficiency (ASMD) is a rare lysosomal storage disorder; a new report said that plasma lyso-sphingomyelin levels can be used to not only diagnose the rare disease but also predict ...
SAN FRANCISCO & SCOTTSDALE, Ariz.--(BUSINESS WIRE)--PicnicHealth, the venture-backed startup giving patients unprecedented access to their medical records and the ability to contribute to scientific ...
Sanofi's Genzyme unit has moved a step closer to securing EU approval for Xenpozyme – its enzyme replacement therapy for rare disease acid sphingomyelinase deficiency (ASMD) – after scoring a positive ...
This diagnostic guideline is intended as an educational resource and represents the opinions of the authors, and is not representative of recommendations or policy of the American College of Medical ...
Sanofi now has approval on both sides of the Atlantic for Xenpozyme – its enzyme replacement therapy for rare disease acid sphingomyelinase deficiency (ASMD) – after getting a green light from the US ...
A recent review examined the significant physical, social, emotional, and financial impacts of acid sphingomyelinase deficiency (ASMD) on patients and caregivers from an overall lifestyle standpoint ...
On October 19, 2023, India marked a significant milestone by commemorating its inaugural ASMD Day, a dedicated day to shed light on the rare genetic condition known as Acid Sphingomyelinase Deficiency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results